PREVIOUS
✖
Zosurabalpin antibiotic
January 8 , 2024
322 days
433
0
- Researchers have identified a new class of antibiotics with the potential to tackle a drug-resistant bacterium, Acinetobacter baumannii.
- Zosurabalpin was found to be effective against CRAB (carbapenem-resistant Acinetobacter baumannii)-induced pneumonia and sepsis in mouse models.
- CRAB was at the top of the World Health Organization’s list of antibiotic-resistant “priority pathogens” in 2017.
- It’s more common in Asia and the Middle East and causes up to 20% of infections in intensive care units worldwide.
Leave a Reply
Your Comment is awaiting moderation.